VGLL3 has been found to modulate glutamine metabolism through regulating the expression of glycinamide ribonucleotide formyltransferase (GART), which encodes a trifunctional enzyme that catalyzes de novo purine synthesis from glutamine in cancer cells [31]. The gene discussed is GART; the disease is cancer.